Search Site

Trends banner

Eni profit falls due to dip in oil prices

Q2 net profit fell by 18% to $637 million.

Emirates NBD H1 profit $3.40bn

Total income rose by 12 percent in the same period.

ADIB H1 pre-tax profit $1.08bn

Q2 pre-tax net profit increases by 14 percent.

AstraZeneca to invest $50bn in US

Bulk of funds to go into a Virginia manufacturing center.

UAB net profit up by 50% for H1

Total assets increase by 11 percent.

Nahdi Medical to list on Tuesday

Ahead of listing, Nahdi generated an order book of $80 billion from institutional investors, while retail subscribers poured in $1.8 billion.
  • With an offer price of SR131 ($35), Nahdi had raised $1.36 billion from its initial public offering, slightly higher than the $1.2 billion sold by ACWA Power a year earlier
  • The Jeddah-based pharma retailer currently operates over 1,150 pharmacies across the Kingdom and a rising number in the UAE

Nahdi Medical Co. of Saudi Arabi will begin trading on March 22 in what is going to be the kingdom’s biggest listing since the listing of Aramco.

With an offer price of SR131 ($35), Nahdi had raised $1.36 billion from its initial public offering, slightly higher than the $1.2 billion sold by ACWA Power a year earlier.

Ahead of listing, Nahdi generated an order book of $80 billion from institutional investors, while retail subscribers poured in $1.8 billion.

The Jeddah-based pharma retailer currently operates over 1,150 pharmacies across the Kingdom and a rising number in the UAE.

With a presence across Saudi Arabia and the UAE, the company held a 31 percent market share of total pharmacy sales in the Kingdom by the end of 2021.